Topics

Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms,Peritoneal Neoplasms,Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 7, Status: Authorised

05:51 EST 14 Feb 2020 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms,Peritoneal Neoplasms,Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 7, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms,Peritoneal Neoplasms,Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 7, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms,Peritoneal Neoplasms,Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 7, Status: Authorised"

Quick Search